Progress, challenge and prospect of tuberculosis drug research and development
ABOUT US
Guangan Bingde Pharmaceutical Co., LTD., established on May 18, 2018, with a registered capital of 23 million yuan, covers an area of 63.9 mu and a plant area of more than 23,000 square meters, is a limited liability company committed to the research and development, production and sales of chemical raw materials and pharmaceutical intermediates. Relying on the scientific research team of Professor Zheng Hu, dean of the College of Original Medicine of Sichuan University, and the Chemical Drug Laboratory of Sichuan University, we carry out the most cutting-edge research on domestic biopharmaceutical and chemical synthetic drugs, and have domestic first-line anti-tuberculosis clinical drugs.
2300公司注册资本(万元)
63.9公司占地面积(亩)
23000+厂房面积(m2)
products
Intermediates of crude drugs for tuberculosis treatment
Molecular formula: C37H45N3O11 CAS number: 13553-79-2
1-amino-4-cyclopentylpiperazine
Intermediates of crude drugs for tuberculosis treatment
Molecular formula: C9H19N3 CAS number: 61379-64-4
Intermediates of crude drugs for tuberculosis treatment
Molecular formula: C43H58N2O12 CAS number: 129791-92-0
Drug substance for tuberculosis
Molecular formula: C43H58N2O12 CAS number: 13292-46-1